Harada, Kazuto
Wang, Xuemei
Shimodaira, Yusuke
Sagebiel, Tara
Bhutani, Manoop S.
Lee, Jeffrey H.
Weston, Brian
Elimova, Elena
Lin, Quan
Amlashi, Fatemeh G.
Mizrak Kaya, Dilsa
Lopez, Anthony
Blum Murphy, Mariela A.
Roth, Jack A.
Swisher, Stephen G.
Skinner, Heath D.
Hofstetter, Wayne L.
Rogers, Jane E.
Thomas, Irene
Maru, Dipen M.
Komaki, Ritsuko
Walsh, Garrett
Ajani, Jaffer A.
Funding for this research was provided by:
National Cancer Institute (CA138671, CA172741, CA129926, CA150334)
Japan Society for the Promotion of Science
Article History
First Online: 7 December 2017
Compliance with Ethical Standards
:
: The original trial was supported by Sanofi Oncology, NJ. This research was supported by generous grants from the Caporella, Dallas, Sultan, Park, Smith, Frazier, Oaks, Vanstekelenberg, Planjery, and Cantu families, as well as from the Schecter Private Foundation, Rivercreek Foundation, Kevin Fund, Myer Fund, Dio Fund, Milrod Fund, and The University of Texas MD Anderson Cancer Center (Houston, Texas, USA) multidisciplinary grant program. This research was also supported in part by the National Cancer Institute and Department of Defense awards CA138671, CA172741, CA129926, CA150334 (J.A.A.), and by a grant from the Japan Society for the Promotion of Science Overseas Research Fellowships and Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (K.H.).
: The authors have no potential conflicts of interest to disclose.